Open access · CC-BY
via OpenAlex
Mesenchymal Stromal Cell Rejuvenation Strategies to Enhance Clinical Translation in Cell Therapy
Astrid Sodomaco, Irene Bernardi, Aretha Rambaldi, Pierluigi Lombardi, Maura Rossi, Francesca Paris, Lucia Manzoli, Stefano Ratti, Francesco Alviano
Aging Cell · 2026
Telomere attrition
Epigenetic alterations
Cellular senescence
Chronic inflammation
Partial reprogramming (OSK)
Human
Review
Abstract
Cell therapies represent a promising frontier in modern medicine. Mesenchymal stromal cells (MSCs) constitute a valuable source due to their minimal ethical concerns, low immunogenicity, negligible tumorigenicity in vivo, and robust paracrine activity mediated by the secretion of anti-inflammatory and angiogenic factors. Despite these advantages, MSCs undergo rapid replicative senescence(definition) accompanied by a progressive loss of stemness markers and functional potency. In this context, cellular rejuvenation has been emerging as a pivotal strategy to restore their original biological features. These approaches aim to modulate the telomere(definition) attrition, cellular senescence)." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">hallmarks of aging(definition); as these processes are highly interconnected, multiple and complementary targets have been proposed. This review aims to discuss and analyze the main rejuvenation strategies reported in the literature for MSCs, with particular attention to approaches that can enhance their functionality and translational potential. In this context, the review focuses on five key categories of interventions: epigenetic modifications, metabolic reprogramming, modulation of cellular senescence, telomere biology, and extracellular vesicles. These strategies represent the fundamental axes through which cellular aging can be counteracted and the efficacy of cell-based therapies improved.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.70672
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Sodomaco, A., Bernardi, I., Rambaldi, A., Lombardi, P., Rossi, M., Paris, F., Manzoli, L., Ratti, S., & Alviano, F. (2026). Mesenchymal Stromal Cell Rejuvenation Strategies to Enhance Clinical Translation in Cell Therapy. <em>Aging Cell</em>. https://doi.org/10.1111/acel.70672
Vancouver
Sodomaco A, Bernardi I, Rambaldi A, Lombardi P, Rossi M, Paris F, et al. Mesenchymal Stromal Cell Rejuvenation Strategies to Enhance Clinical Translation in Cell Therapy. Aging Cell. 2026. doi:10.1111/acel.70672.
BibTeX
@article{astrid2026Mesenc,
title = {Mesenchymal Stromal Cell Rejuvenation Strategies to Enhance Clinical Translation in Cell Therapy},
author = {Astrid Sodomaco and Irene Bernardi and Aretha Rambaldi and Pierluigi Lombardi and Maura Rossi and Francesca Paris and Lucia Manzoli and Stefano Ratti and Francesco Alviano},
journal = {Aging Cell},
year = {2026},
doi = {10.1111/acel.70672},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging cell 2026
Open access · OA
Mesenchymal Stromal Cell Rejuvenation Strategies to Enhance Clinical Translation in Cell Therapy.
Biogerontology 2026
Open access · OA
Mesenchymal stem/stromal cell senescence in aging and regenerative medicine: a systematic review.
Astana Medical Journal 2026
Open access · OA
Mesenchymal Stem Cells in Regenerative Therapy: Therapeutic Potential and Applications
World Journal of Stem Cells 2020
Open access · CC-BY
Senescent mesenchymal stem/stromal cells and restoring their cellular functions
Frontiers in Bioengineering and Biotechnology 2025
Open access · CC-BY
Mesenchymal stem cells and their extracellular vesicles: new therapies for cartilage repair
Medical review (2021) 2025
Open access · OA